FDA Approves First Treatment for MacTel episode artwork

EPISODE · Mar 12, 2025 · 8 MIN

FDA Approves First Treatment for MacTel

from Eyewire News: The Podcast · host Eyewire News

The CEO of Neurotech joins us to talk about the FDA approval of the first treatment for MacTel; a target action date is set for Sydnexis’ pediatric myopia treatment candidate; and three eye care companies collaborate to launch a wearable vision testing platform. Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

FDA Approves First Treatment for MacTel

0:00 8:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 8 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on March 12, 2025.

What is this episode about?

The CEO of Neurotech joins us to talk about the FDA approval of the first treatment for MacTel; a target action date is set for Sydnexis’ pediatric myopia treatment candidate; and three eye care companies collaborate to launch a wearable vision...

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!